“showed a trend”

The results showed a trend similar to that of the CCK‐8 assay (Figure 2D ).

Additionally, basal oxygen consumption rate, maximal oxygen consumption rate, and ATP production showed a trend toward the same effect (Figure 4 F, G).

Grade I samples ( N = 6) showed a trend towards decrease, but were not statistically different to NAT (Figure 3A ).

The proteins IL-6, CXCL10, CCL2 and PDGF-BB were significantly upregulated by adipose-EC, the secretion by dermal-EC showed a trend towards increased secretion.

In univariate analysis, age > 55 years (HR: 2.570; 95% CI: 0.839–7.873; P = 0.09) and EBMT risk scores > 4 (HR: 2.721; 95% CI: 0.850–8.712; P = 0.09) showed a trend of significance.

Post-program Rankings Dependent t tests showed a trend for patients to have changed their prioritization of caregiver burden after participation in the HABIT program.

In the SYLP group, ΔH also showed a trend of decreasing first and then increasing.

The same concentration of JNJ-54271074 showed a trend of decreasing IL-22, TNFα and GM-CSF production, while slightly increasing IFNγ production.

In addition, chromosomal damage, such as micronuclei frequencies or NPBs showed a trend to decrease in all three groups 28 .

In the light period, the results showed a trend to an increased LMR, even though the effect was not significant.

At baseline, all groups showed a trend of a slight decline in brain arousal regulation over the recording period, with ED+ with comorbid depressive symptoms being somewhat more vigilant in terms of higher EEG-vigilance level compared to ED+ without comorbid depressive symptoms.

At the sixth month, the VL/HIV-NR group showed a trend towards decreased activation levels, but a significant reduction was observed at 12 mpt in this group compared to the VL/HIV-R group (**p<0.01).

RSV-treated hearts (D8_RSV group) showed a trend towards an enhancement of anti-inflammatory CD163 pos macrophages with a parallel partial reduction of pro-inflammatory CD40 pos cells ( Figure 8 a,b), leading to a significant reduction (approximately −50%) in the CD40 pos /CD163 pos macrophage ratio observed in D8 hearts ( Figure 8 c). 3.2.4.

In addition, soy leaves have been reported to reduce non-HDL cholesterol, although serum total cholesterol showed a trend of lowering effects in hamsters [ 26 ].

TUBB3, SOX12 and ALDH1L1, that are downregulated by Nup153 ( Toda et al., 2017 ), showed a trend for increased expression in RV infected samples ( Figure 2A ).

The mice in the drinking group showed a trend of anxiety and depression during drinking and the trend increased after alcohol withdrawal.

(2021) showed a trend toward an increased abundance of Firmicutes and a decreased abundance of Bacteroidetes in patients with NAFLD; however, the results from the studies by Zhang Y. et al.

Analysis of frozen PBMC from five patients with RA (three CC and two CT) showed a trend in increased frequency of tetramer-positive B cells in the patients carrying the PTPN22 risk allele (Fig. 3b ).

In contrast, it showed a trend towards decreased expression of CD9, CD81, CD123, CD13, CD15 and CD21.

During the entire treatment period, metformin-treated mice showed a trend towards a longer life span (Fig. 3B ).

Mature MMP-3 levels showed a trend towards an increased expression in both the retina and RPE after LPS injection ( Figure 1 B,C).

However when CsA was added to the DM1 myoblasts with paxilline, MMP-2 levels in the secretion showed a trend towards efficacy with an increase by 67% although analysis showed no statistical effect ( Figure 3d ).

Furthermore, isorhamnetin + caffeic acid showed a trend of synergism in which 1:1 displayed the strongest synergism (γ = 1.536).

Comorbidities, rated as having an extreme influence on CRC screening, showed a trend toward lower screening rates, suggesting that, although comorbidities did not predict colonoscopy completion, they may play a role in relation to other factors 44 .

This finding is consistent with the study of Eloot et al that showed a trend of decreasing unbound percentage of IS in CKD subjects with the progression of chronic renal failure. 15 A crude estimation from their data reveals the unbound percentage of IS is 21.3% for stage II, 11.5% for stage III, 8.7% for stage IV, and 6.5% for stage V CKD.